The Food and Drug Administration (FDA) approved a twice-yearly injection developed to prevent HIV.
The first and only of its kind drug, manufactured by Gilead Sciences, will be sold under the name Yeztugo (lenacapavir).
WATCH:
#GileadNews: The FDA has approved our injectable HIV-1 prevention medication, making it the first
Continue reading

Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!